Skip to main content
Equibles

Ensign Peak Advisors, Inc

Position in DYN — Dyne Therapeutics, Inc.

CIK 1454984 SALT LAKE CITY, UT
Back to DYN Full portfolio

Position in DYN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,434,903
-$2,568,273 QoQ
Shares Held
289,730
-41.7% QoQ
Ownership
0.155%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DYN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ensign Peak Advisors, Inc holds $1,119,129,230 across 124 Biotechnology names. DYN ranks #46 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 210,483 $104,553,220
2 INSM
INSMED Inc
 702,951 $74,948,635
3 ABVX
Abivax S.A.
 504,471 $67,225,805
4 BBIO
BridgeBio Pharma, Inc.
 760,977 $56,677,566
5 ARGX
Argenx SE
 52,027 $48,269,089
6 PTCT
Ptc Therapeutics, Inc.
 508,056 $41,442,127
7 TVTX
Travere Therapeutics, Inc.
 591,815 $33,621,010
8 SRRK
Scholar Rock Holding Corp
 579,052 $31,847,860

All Filings in DYN

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,434,903 289,730
2026-03-31 $9,003,176 496,590
2025-12-31 $9,713,300 496,590
2025-09-30 $254,897 20,150
2025-06-30 $2,533,014 266,073
2025-03-31 $210,769 20,150
2024-12-31 $7,435,583 315,602
2024-09-30 $11,234,051 312,752
2024-06-30 $11,037,018 312,752
2024-03-31 $17,354,608 611,293
2023-12-31 $6,800,196 511,293
2023-09-30 $4,581,185 511,293
2023-06-30 $5,752,046 511,293
2023-03-31 $2,610,731 226,626
2022-12-31 $463,600 40,000
2022-09-30 $562,229 44,270
2022-06-30 $274,800 40,000
2022-03-31 $385,600 40,000
2021-12-31 $475,600 40,000
2021-09-30 $649,600 40,000
2021-06-30 $841,600 40,000
2021-03-31 $621,200 40,000
2020-12-31 $840,000 40,000
2020-09-30 $807,600 40,000